Search results
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 10 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 4 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 3 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 14 hours agoA: John Trizzino, Novavax, Inc. - President & Chief Operating Officer...increase market share and vaccination rates through the combination of COVID and flu vaccines ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 4 days ago...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 3 days agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WFRV 5 Green Bay· 4 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 3 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...